BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN
Delisted
BHVN was delisted on the 3rd of October, 2022.
102 hedge funds and large institutions have $1.19B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2018 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 37 increasing their positions, 33 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
12% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 33
2% more funds holding
Funds holding: 100 → 102 (+2)
Holders
102
Holding in Top 10
6
Calls
$18.4M
Puts
$3.19M
Top Buyers
| 1 | +$38.8M | |
| 2 | +$33.4M | |
| 3 | +$20.1M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$16.2M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$13.6M |
Top Sellers
| 1 | -$18.6M | |
| 2 | -$14.2M | |
| 3 | -$9.37M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$7.26M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$4.18M |